EE98 A Budget Impact Analysis of Empagliflozin for Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Tertiary Hospital, Riyadh, Saudi Arabia
Abstract
Authors
S Alhawwashi S Alqahtani S Alyahya